NIUM develops IMAT, a patented gut-on-a-chip platform that lets companies test foods, probiotics, and drugs on realistic gut models. Our system uses a co-culture of human cells and microbes for accurate, high-throughput studies. We generate revenue through testing services, device and cartridge sales, and cloud analytics subscriptions.